Telo Genomics Corp. to File Statement of Defence and Counterclaim to Lawsuit Filed by Former President
Telo Genomics Corp. (TSXV: TELO) (OTCQB: TDSGF) announced it has received a Statement of Claim from its former President, Sherif Louis, who is seeking approximately $530,000 in alleged unpaid notice and bonuses. The Company stated it intends to vigorously defend against the claim and will file a statement of defence and counterclaim in response.
The announcement represents a legal dispute between the Company and its former executive, with potential financial implications depending on the outcome of the legal proceedings.
Telo Genomics Corp. (TSXV: TELO) (OTCQB: TDSGF) ha comunicato di aver ricevuto un Atto di Citazione da parte del suo ex Presidente, Sherif Louis, che richiede circa 530.000 dollari per presunti mancati pagamenti di preavviso e bonus. La Societ脿 ha dichiarato di voler difendersi con decisione contro la richiesta e di presentare una memoria difensiva e una controquerela in risposta.
L'annuncio riguarda una controversia legale tra la Societ脿 e il suo ex dirigente, con possibili implicazioni finanziarie a seconda dell'esito del procedimento giudiziario.
Telo Genomics Corp. (TSXV: TELO) (OTCQB: TDSGF) anunci贸 que ha recibido una Demanda por parte de su ex Presidente, Sherif Louis, quien reclama aproximadamente 530,000 d贸lares por presuntos salarios y bonificaciones no pagados. La Compa帽铆a declar贸 que tiene la intenci贸n de defenderse en茅rgicamente contra la demanda y presentar谩 una declaraci贸n de defensa y una contrademanda en respuesta.
El anuncio representa una disputa legal entre la Compa帽铆a y su ex ejecutivo, con posibles implicaciones financieras dependiendo del resultado del proceso judicial.
Telo Genomics Corp. (TSXV: TELO) (OTCQB: TDSGF)電� 鞝� 靷灔 靺半Μ頂� 耄澊鞀る攵�韯� 鞎� 530,000雼煬鞚� 氙胳旮� 韱奠 氚� 氤措剤鞀� 觳惮毳� 鞖旉惮頃橂姅 靻岇灔鞚� 鞝戩垬頄堧嫟瓿� 氚滍憸頄堨姷雼堧嫟. 須岇偓電� 鞚� 觳惮鞐� 雽�頃� 臧曤牓頌� 雽�鞚戫暊 瓿勴殟鞚措┌, 鞚挫棎 雽�頃� 雼惦硛靹� 氚� 氚橃唽毳� 鞝滌稖頃� 鞓堨爼鞛呺媹雼�.
鞚措矆 氚滍憸電� 須岇偓鞕� 鞝� 鞛勳洂 臧勳潣 氩曥爜 攵勳焷鞚� 鞚橂頃橂┌, 氩曥爜 鞝堨皑 瓴瓣臣鞐� 霐半澕 鞛爼鞝� 鞓來枼鞚� 鞛堨潉 靾� 鞛堨姷雼堧嫟.
Telo Genomics Corp. (TSXV : TELO) (OTCQB : TDSGF) a annonc茅 avoir re莽u une assignation de son ancien pr茅sident, Sherif Louis, qui r茅clame environ 530 000 $ pour des indemnit茅s de pr茅avis et des primes pr茅tendument impay茅es. La soci茅t茅 a d茅clar茅 son intention de se d茅fendre vigoureusement contre cette r茅clamation et de d茅poser une d茅claration de d茅fense ainsi qu'une demande reconventionnelle en r茅ponse.
Cette annonce concerne un litige juridique entre la soci茅t茅 et son ancien cadre, avec des implications financi猫res potentielles selon l鈥檌ssue de la proc茅dure judiciaire.
Telo Genomics Corp. (TSXV: TELO) (OTCQB: TDSGF) gab bekannt, dass sie eine Klageschrift von ihrem ehemaligen Pr盲sidenten Sherif Louis erhalten hat, der etwa 530.000 US-Dollar an angeblich nicht gezahlten Abfindungen und Boni fordert. Das Unternehmen erkl盲rte, es beabsichtige, die Klage energisch zu verteidigen und eine Erwiderung sowie eine Widerklage einzureichen.
Die Bekanntgabe stellt einen Rechtsstreit zwischen dem Unternehmen und seinem ehemaligen Gesch盲ftsf眉hrer dar, mit m枚glichen finanziellen Auswirkungen abh盲ngig vom Ausgang des Verfahrens.
- None.
- Legal claim of $530,000 filed against the company by former President
- Potential financial liability and legal expenses from lawsuit defense
Toronto, Ontario--(Newsfile Corp. - June 30, 2025) - Telo Genomics Corp. (TSXV: TELO) (OTCQB: TDSGF) (the "Company" or "Telo Genomics") has received a Statement of Claim filed by Sherif Louis, the former President of the Company, in the amount of approximately
For further information, please contact:
Guido Baechler
Executive Chairman
647-477-9365
[email protected]
MaRS Centre, South Tower
101 College Street, Suite 200
Toronto, ON, M5G 1L7
Neither the TSX Venture Exchange nor its Regulation Services Provider (as such term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Cautionary Note Regarding Forward-Looking Statements
Certain information contained herein may constitute "forward-looking information" under Canadian securities legislation. Generally, forward-looking information can be identified by the use of forward-looking terminology such as "intends", or variations of such words and phrases or statements that certain actions, events or results "will" occur. Certain forward-looking statements, including statements regarding the Company's the amounts claimed and the Company's intent to defend the claim are subject to known and unknown risks, uncertainties and other factors that may cause the actual outcome to be materially different from those expressed or implied by such forward-looking statements or forward-looking information.. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements and forward-looking information. The Company will not update any forward-looking statements or forward-looking information that are incorporated by reference herein, except as required by applicable securities laws.
To view the source version of this press release, please visit
FAQ
How much is the former President of Telo Genomics (TDSGF) claiming in the lawsuit?
What is Telo Genomics' (TDSGF) response to the lawsuit filed by its former President?
Who filed the lawsuit against Telo Genomics (TDSGF)?
What is the basis for the lawsuit against Telo Genomics (TDSGF)?
